Contact
searchSearch
HMP Global

Alopecia Areata Excellence Forum

Featured

Alopecia
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Dr Brett King
Videos
Expectations for JAK Inhibitor Treatment of Alopecia Areata
03/04/2026
Brett A. King, MD, PhD; Jessica Garlewicz
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are...
03/04/2026
The Dermatologist
Puzzle pieces
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist
Young woman in distress
Quiz
Psychological and Functional Impact of Eyebrow and Eyelash Loss in AA
02/05/2026
Riya Gandhi, MA
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and...
02/05/2026
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation...
02/01/2026
The Dermatologist
NAAF-Reviewed Content
Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy
01/30/2026
Brett A. King, MD, PhD
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the...
01/30/2026
The Dermatologist
Physician with patient
Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
alopecia areata
Conference Coverage
JAK Inhibitors in Alopecia Areata: Long-Term Success, Individualized Strategy, and the Emerging Role of Eyebrow Outcomes
11/26/2025
Jessica Garlewicz
Through patient cases and data review, the presenters emphasized the need to think beyond the scalp, personalize treatment duration and dosing, and recognize the growing significance of eyebrow regrowth as a marker of patient satisfaction.
Through patient cases and data review, the presenters emphasized the need to think beyond the scalp, personalize treatment duration and dosing, and recognize the growing significance of eyebrow regrowth as a marker of patient satisfaction.
Through patient cases and data...
11/26/2025
The Dermatologist
Natasha Atanaskova-Mesinkovska, MD, PhD
Conference Coverage
JAK Inhibitors for Alopecia Areata: Clinical Insights and Emerging Strategies
10/28/2025
Jessica Garlewicz
At Fall Clinical 2025, Natasha Atanaskova-Mesinkovska, MD, PhD, presented a candid and case-based review of current treatment strategies for alopecia areata.
At Fall Clinical 2025, Natasha Atanaskova-Mesinkovska, MD, PhD, presented a candid and case-based review of current treatment strategies for alopecia areata.
At Fall Clinical 2025, Natasha...
10/28/2025
The Dermatologist

From the Journal

NAAF-Reviewed Content
Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy
01/30/2026
Brett A. King, MD, PhD
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the...
01/30/2026
The Dermatologist
NAAF-Reviewed Content
Psychosocial Impact of Alopecia Areata in Pediatric Populations
10/06/2025
Riya Gandhi, MA
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health...
10/06/2025
The Dermatologist
Cover Story
Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue
09/08/2025
Justin M. Ko, MD, MBA
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares...
09/08/2025
The Dermatologist
NAAF-Reviewed Content
The Impact of Eyebrow and Eyelash Loss
05/01/2025
Riya Gandhi, MA
Discover why addressing eyebrow and eyelash regrowth is becoming an essential part of alopecia areata care.
Discover why addressing eyebrow and eyelash regrowth is becoming an essential part of alopecia areata care.
Discover why addressing eyebrow...
05/01/2025
The Dermatologist
NAAF-Reviewed Content
Managing Pediatric Alopecia Areata: Part 2
02/03/2025
Riya Gandhi, MA
Although there is no one-size-fits-all approach, alopecia areata is becoming a treatable disease in children and adolescents.
Although there is no one-size-fits-all approach, alopecia areata is becoming a treatable disease in children and adolescents.
Although there is no...
02/03/2025
The Dermatologist
NAAF-Reviewed Content
Managing Pediatric Alopecia Areata: Part 1
12/02/2024
Riya Gandhi, MA
Alopecia areata is one of the most common hair loss disorders seen in children presenting with hair loss.
Alopecia areata is one of the most common hair loss disorders seen in children presenting with hair loss.
Alopecia areata is one of the...
12/02/2024
The Dermatologist
NAAF-Reviewed Content
Prevalence and Management of Alopecia Areata in Black and Asian Patients
09/06/2024
Riya Gandhi, MA
This interview highlights the importance of culturally sensitive care and the need for equitable access to treatment options for all patients, regardless of race or ethnicity.
This interview highlights the importance of culturally sensitive care and the need for equitable access to treatment options for all patients, regardless of race or ethnicity.
This interview highlights the...
09/06/2024
The Dermatologist
NAAF-Reviewed Content
Improving Lives With Alopecia Areata Treatment
06/06/2024
Riya Gandhi, MA
Dr Arash Mostaghimi discusses innovative approaches for meaningful hair regrowth and the role of patient advocacy in supporting those affected by this autoimmune disease.
Dr Arash Mostaghimi discusses innovative approaches for meaningful hair regrowth and the role of patient advocacy in supporting those affected by this autoimmune disease.
Dr Arash Mostaghimi discusses...
06/06/2024
The Dermatologist
NAAF-Reviewed Content
Resources for Patients With Alopecia Areata
12/05/2023
Coleen Stern, MA
Connecting patients with trusted information and support can increase their quality of life.
Connecting patients with trusted information and support can increase their quality of life.
Connecting patients with trusted...
12/05/2023
The Dermatologist
NAAF-Reviewed Content
Advances in Alopecia Areata Treatment and Assessment
09/11/2023
Coleen Stern, MA
“With recent advancements, the care of patients with alopecia areata has changed forever and so has dermatology,” shares Dr Brett King.
“With recent advancements, the care of patients with alopecia areata has changed forever and so has dermatology,” shares Dr Brett King.
“With recent advancements, the...
09/11/2023
The Dermatologist
Case Report
Phototoxic Drug Eruption to Novel Anticancer Agent Pidnarulex
10/05/2026
Shannon C. Lyden, BS; Priya Gupta, BA; Ernest Moore, BA; Nabiha Islam, MD; Brittany Dulmage, MD; Abraham M. Korman, MD
Prompt dermatologic recognition of this reaction pattern, combined with dose adjustment rather than discontinuation, may allow patients to safely continue a promising anticancer therapy.
Prompt dermatologic recognition of this reaction pattern, combined with dose adjustment rather than discontinuation, may allow patients to safely continue a promising anticancer therapy.
Prompt dermatologic recognition...
10/05/2026
The Dermatologist
Derm Dx
What Caused This Hyperpigmentation?
10/02/2026
Lanah Almatroud, BA; Rania Djemil, BS; Amor Khachemoune, MD, FAAD, FACMS
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran,...
10/02/2026
The Dermatologist
Cover Story
The Industry Dermatologist: Building a Career at the Intersection of Science, Innovation, and Patient Care
10/02/2026
Ayman Grada, MD, MHA; Riya Gandhi, MA
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his...
10/02/2026
The Dermatologist
Cover Story
Dermatology in the Digital Age: How Technology Is Transforming Clinical Practice
09/03/2026
Daniel M. Siegel, MD, MS, FAAD, FACMS; Riya Gandhi, MA
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness...
09/03/2026
The Dermatologist
Feature Story
The Eye-Skin Connection: Ocular Red Flags Every Dermatologist Should Know
09/03/2026
Jennifer Cao, MD; Riya Gandhi, MA
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular...
09/03/2026
The Dermatologist
Derm Dx
What Is the Cause of This Color Change on the Neck?
09/03/2026
Sümeyye Aktaş, MD; Mehmet Ali Demirci, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented...
09/03/2026
The Dermatologist
Case Report
Reed Nevus
09/03/2026
Lanah Almatroud, BA; Rania Djemil, BS; Şükrü Yildirim, MD, PhD; Elif Müyesseroğlu; Amor Khachemoune, MD, FAAD, FACMS
In this benign, genetically defined spitzoid lesion, characteristic pigmentation and spindle cell morphology reflect underlying kinase-driven pathways rather than malignant potential.
In this benign, genetically defined spitzoid lesion, characteristic pigmentation and spindle cell morphology reflect underlying kinase-driven pathways rather than malignant potential.
In this benign, genetically...
09/03/2026
The Dermatologist
Feature Story
Special Delivery of Topical Interest: Understanding Vehicle Formulation for Nonsteroidal Prescription Eczema Creams
08/04/2026
Julia Ross, MD; Noah A. Levit, MD, PhD, FAAD
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the...
08/04/2026
The Dermatologist
Derm Dx
What Are These Pigmented, Pedunculated Lesions?
08/04/2026
Tanya Henry, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American...
08/04/2026
The Dermatologist
Case Report
Recurrent Inflammatory Plaques on Upper Extremities in a Patient With Breast Cancer Surgery History
08/04/2026
Shannon C. Lyden, BS; Abraham M. Korman, MD
The presented case aims to improve the recognition of intravascular histiocytosis, a rare reactive skin condition.
The presented case aims to improve the recognition of intravascular histiocytosis, a rare reactive skin condition.
The presented case aims to...
08/04/2026
The Dermatologist

Expert Insights

Dr Brett King
Videos
Expectations for JAK Inhibitor Treatment of Alopecia Areata
03/04/2026
Brett A. King, MD, PhD; Jessica Garlewicz
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are...
03/04/2026
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation...
02/01/2026
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
Dr Amy McMichael
Videos
The Complexities of Diagnosing and Assessing Alopecia Areata
12/20/2024
Amy J. McMichael, MD
In this video, Amy J McMichael, MD, FAAD, discusses the complexities encountered when diagnosing alopecia areata; the currently available disease severity assessment tools, along with the benefits and shortcomings of each tool; and where the...
In this video, Amy J McMichael, MD, FAAD, discusses the complexities encountered when diagnosing alopecia areata; the currently available disease severity assessment tools, along with the benefits and shortcomings of each tool; and where the...
In this video, Amy J McMichael,...
12/20/2024
The Dermatologist
Dr Peter Lio
Videos
Insights From Mount Sinai Winter Symposium: Holistic Approaches Treating Alopecia Areata
12/07/2023
Peter Lio, MD, FAAD
In this feature video, Dr Peter Lio discussed holistic treatments for conditions like atopic dermatitis and alopecia areata.
In this feature video, Dr Peter Lio discussed holistic treatments for conditions like atopic dermatitis and alopecia areata.
In this feature video, Dr Peter...
12/07/2023
The Dermatologist
Cathryn Sibbald MD, MSc, FRCPC, DAB
Videos
JAK Inhibitors for Alopecia Areata
10/19/2023
Cathryn Sibbald, MD, MSc, FRCPC
In this feature video, Dr Cathryn Sibbald shares the mechanism of action behind JAK inhibitors utilized to treat alopecia areata.
In this feature video, Dr Cathryn Sibbald shares the mechanism of action behind JAK inhibitors utilized to treat alopecia areata.
In this feature video, Dr...
10/19/2023
The Dermatologist
Dr Lisa Swanson
Videos
Pediatric Atopic Dermatitis: Diagnosis, Treatment Selection, and Long-Term Health Considerations
11/03/2026
Elizabeth Swanson, MD; Jessica Garlewicz
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the...
11/03/2026
The Dermatologist
KOL Roundtable
Videos
Type 2 Inflammation as an Underlying Disease Driver
11/02/2026
Raj Chovatiya, MD, PhD; Tina Bhutani, MD, MAS; Daniel C. Butler, MD; Jason Ezra Hawkes, MD, MS, FAAD
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an...
11/02/2026
The Dermatologist
Brian Kim
Videos
From Cytokines to Clinic: Translating Type 2 Biology Into Prurigo Nodularis Treatment
11/01/2026
Brian Kim, MD, MTR, FAAD; Riya Gandhi, MA
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4...
11/01/2026
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Dr Martina Porter
Videos
Expert Insights: Povorcitinib for Hidradenitis Suppurativa
10/15/2026
Martina Porter, MD; Jessica Garlewicz
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50...
10/15/2026
The Dermatologist
Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz; Elizabeth Swanson, MD
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes

Alopecia
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Puzzle pieces
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist
Young woman in distress
Quiz
Psychological and Functional Impact of Eyebrow and Eyelash Loss in AA
02/05/2026
Riya Gandhi, MA
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and...
02/05/2026
The Dermatologist
Physician with patient
Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Physician with child
Quiz
Pediatric Patients With Atopic Dermatitis Receiving Dupilumab
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
Therapeutic Response Heterogeneity and Precision Medicine in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
Neuroimmune Interactions and Disease Persistence in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
Understanding Type 2 Inflammation Across Inflammatory Skin Diseases
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
Advanced Therapeutic Sequencing and Personalized Care in Type 2 Inflammatory Skin Disease
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use